HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
about
Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa.Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum.Hidradenitis suppurativa: an update on connecting the tracts.Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials.Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.Prevalence of positive QuantiFERON gold in-tube testing in hidradenitis suppurativa.Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients.Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
P2860
Q38732070-9A06708D-FC41-47D7-B2E1-33305985890AQ38929328-281D9CF8-06EC-444B-A154-37DA271CD6AEQ39032625-E5A3C0EE-7F30-4D0D-84C3-9FA8A6B2D276Q40881042-87E46698-B3E4-4F5C-8CA2-4B60484D00DFQ41196480-167C6962-5C74-447D-9BAF-AC50120440BCQ45945673-349DA5A3-6166-4D67-96F0-F850F851BD1BQ46523228-3250A4E2-8B53-4B7C-B8B5-D149D9281349Q48258620-CD6C6041-A834-4870-8D45-60072D775EC1Q50294182-FF7700ED-1856-47EC-A906-AE44BA5E58D0Q58124400-CD878924-57C1-44B7-B375-6D54B3266A7B
P2860
HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HiSCR (Hidradenitis Suppurativ ...... of a phase 2 adalimumab study.
@en
HiSCR
@nl
type
label
HiSCR (Hidradenitis Suppurativ ...... of a phase 2 adalimumab study.
@en
HiSCR
@nl
prefLabel
HiSCR (Hidradenitis Suppurativ ...... of a phase 2 adalimumab study.
@en
HiSCR
@nl
P2093
P2860
P356
P1476
HiSCR (Hidradenitis Suppurativ ...... of a phase 2 adalimumab study.
@en
P2093
C C Zouboulis
D A Williams
H D Teixeira
J M Sobell
M Sundaram
P2860
P304
P356
10.1111/JDV.13216
P577
2015-07-22T00:00:00Z